Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study

Br J Dermatol. 2021 Feb;184(2):350-352. doi: 10.1111/bjd.19478. Epub 2020 Sep 24.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal, Humanized
  • Cohort Studies
  • Hidradenitis Suppurativa* / drug therapy
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • brodalumab
  • Adalimumab